Mutations of tumor suppressor genes tuberous sclerosis complex 1 (TSC1) and TSC2 are linked to the pathobiology of hamartoma syndrome Tuberous Sclerosis (TSC) and pulmonary lymphangioleiomyomatosis (LAM) [1]–[5]. Here, TSC1 is linked to lymphangioleiomyomatosis.